Global Modular Laboratory Automation Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Free Sample Report 無料サンプルレポート Inquire Before Buying 事前に問い合わせる Buy Now今すぐ購入

Global Modular Laboratory Automation Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Medical Devices
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 ページ
  • テーブル数: 220
  • 図の数: 60

Global Modular Laboratory Automation Market Size, Share, and Trends Analysis Report

Market Size in USD Billion

CAGR :  % Diagram

Chart Image USD 8.98 Billion USD 15.15 Billion 2024 2032
Diagram 予測期間
2025 –2032
Diagram 市場規模(基準年)
USD 8.98 Billion
Diagram Market Size (Forecast Year)
USD 15.15 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Thermo Fisher ScientificInc.
  • Danaher
  • BD
  • Abbott
  • Hamilton Company.

Global Modular Laboratory Automation Market Segmentation, By Equipment and Software (Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, ASRS, Software, and Analysers), Application (Drug Discovery, Genomics, Proteomics, and Clinical Diagnostics) – Industry Trends and Forecast to 2032

モジュラーラボオートメーション市場

Modular Laboratory Automation Market Analysis

The modular laboratory automation market is experiencing significant growth, driven by advancements in technology and the increasing demand for efficient, scalable solutions in laboratory environments. As laboratories face rising pressure to improve productivity, reduce human error, and handle complex workflows, modular automation systems offer a flexible approach by allowing labs to integrate various modules according to specific needs.

Key factors driving the market include the growing focus on precision and accuracy in scientific research, as well as the need for laboratories to cope with high-throughput demands. Automation systems enable faster sample processing, enhanced data management, and consistent results, making them essential in fields such as pharmaceuticals, biotechnology, and academic research.

In addition, the demand for personalized and customizable solutions has encouraged vendors to develop highly adaptable platforms, capable of supporting multiple tasks such as liquid handling, sample preparation, and data analysis. As the market continues to evolve, automation solutions are expected to become increasingly sophisticated, integrating artificial intelligence and machine learning for improved decision-making and efficiency.

The modularity of these systems also ensures scalability, allowing laboratories to expand or modify their automation setups with minimal disruption. This flexibility, along with cost and time-saving benefits, is expected to continue driving the market forward in the coming years.

Modular Laboratory Automation Market Size

The global modular laboratory automation market size was valued at USD 8.98 billion in 2024 and is projected to reach USD 15.15 billion by 2032, with a CAGR of 6.76% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Modular Laboratory Automation Market Trends

“Demand for Increased Efficiency and Accuracy in Laboratory Processes”

The modular laboratory automation market is trending because of the growing demand for increased efficiency and accuracy in laboratory processes. As laboratories are handling more complex experiments, larger volumes of samples, and a greater need for precision, traditional manual methods are no longer sufficient. Modular automation systems address these challenges by streamlining workflows, reducing human error, and significantly speeding up repetitive tasks such as sample preparation, testing, and data analysis.

These systems can be easily customized and scaled, allowing laboratories to start with essential modules and expand as needed without overhauling entire setups. This flexibility is especially appealing to labs in industries such as pharmaceuticals, biotechnology, and academic research, where the ability to quickly adapt to changing demands is crucial. As such, modular laboratory automation not only boosts productivity but also helps ensure high-quality, consistent results, making it a highly attractive solution for modern laboratories.

Report Scope and Modular Laboratory Automation Market Segmentation         

Attributes

Modular Laboratory Automation Key Market Insights

Segments Covered

  • By Equipment and Software: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, ASRS, Software, and Analysers
  • By Application: Drug Discovery, Genomics, Proteomics, and Clinical Diagnostics

Countries Covered

U.S., Canada and Mexico, Germany, France, U.K., Italy, Russia, Spain, Denmark, Sweden, Norway, Rest of Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Nigeria, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America

Key Market Players

Abbott (U.S.), Agilent Technologies, Inc. (U.S.), Aurora Biomed Inc. (Canada), BD (U.S.), BIOMÉRIEUX (France), BioTek Instruments, Inc. (U.S.), Brooks Automation US, LCC (U.S.), Danaher Corporation (U.S.), Eppendorf SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Honeywell International Inc. (U.S.), Hudson Robotics (U.S.), Hamilton Company (U.S.), Interscience (France), Oracle (U.S.), PerkinElmer (U.S.), QIAGEN (Germany), Synchron (The Netherlands), Siemens (Germany) and Thermo Fisher Scientific Inc. (U.S.)

Market Opportunities

  • Integration of Artificial Intelligence and Machine Learning
  • Rising Demand for Personalized Medicine

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Modular Laboratory Automation Market Definition

Modular Laboratory Automation refers to a flexible and customizable system designed to automate various laboratory processes by using interchangeable and scalable modules. These modules can be combined and configured to perform specific tasks such as sample preparation, liquid handling, analysis, and data management, depending on the laboratory’s requirements. The modular approach allows labs to start with basic automation and expand their system incrementally as needs grow, without requiring a complete overhaul. This adaptability enhances efficiency, reduces human error, and improves accuracy, making it particularly useful in high-throughput environments or research settings where precision and consistency are critical.

Modular Laboratory Automation Market Dynamics

Drivers

  • Increased Demand for High-Throughput Testing

The growing need for high-throughput testing across industries such as pharmaceuticals, biotechnology, and healthcare is a significant driver of the modular laboratory automation market. As scientific research advances, laboratories face the challenge of processing larger volumes of samples efficiently while maintaining high accuracy and precision. Modular automation systems enable labs to streamline repetitive tasks such as sample preparation, analysis, and data management, boosting throughput without compromising quality. For instance, in pharmaceutical research, where drug discovery and clinical testing require extensive sample testing, modular automation systems can quickly process thousands of samples, allowing researchers to focus on analysis rather than manual labor. Similarly, in clinical diagnostics, automation enables faster and more accurate testing for diseases, enhancing productivity and reducing waiting times for results. These capabilities address the growing need for efficiency in modern labs, driving the adoption of modular automation solutions that offer flexibility and scalability, thereby fueling market growth.

  • Reduction of Human Error and Improved Accuracy

A critical factor fueling the growth of the market is reducing human error and enhancing the accuracy of lab results. Manual tasks, such as sample handling and data analysis, are prone to inconsistencies, leading to unreliable results and potential risks in scientific research or clinical diagnoses. Modular automation systems significantly minimize the chance of error by automating repetitive processes, ensuring precision, and maintaining consistency. For instance, in research laboratories conducting experiments with complex protocols, human mistakes can lead to costly setbacks. Modular systems such as liquid handling robots can ensure exact volumes are measured every time, preventing errors related to human fatigue or oversight. In the biotechnology industry, where sample contamination or inaccurate measurements can compromise results, automation provides a higher level of control, reliability, and reproducibility. This enhanced accuracy is especially important in highly regulated fields such as pharmaceuticals and medical diagnostics, further driving the market growth.

Opportunities

  • Integration of Artificial Intelligence and Machine Learning

One major opportunity in the modular laboratory automation market is the integration of artificial intelligence and machine learning to enhance decision-making and streamline lab processes. AI and ML can help automate complex data analysis, optimize workflows, and even predict future trends based on experimental data, offering a new level of intelligence to automation systems. For instance, in drug development, AI-driven automation can analyze large datasets from multiple experiments to identify patterns that might otherwise go unnoticed, enabling researchers to make faster, data-backed decisions. Similarly, in diagnostics, AI can assist in interpreting results more accurately and even flag potential anomalies, enhancing the overall reliability and efficiency of testing. As these technologies continue to evolve, integrating them into modular laboratory automation systems opens new possibilities for the market.

  • Rising Demand for Personalized Medicine

The increasing focus on personalized medicine presents a significant opportunity for the market. Personalized medicine requires precise, tailored approaches to healthcare, which often involves high-throughput screening and testing of individual patient data. Modular automation systems, which can be easily customized and scaled, offer the flexibility needed to handle these diverse and complex tasks efficiently. For instance, in genomic research, automation can expedite the analysis of DNA sequences, enabling researchers to identify genetic variations specific to individual patients. Similarly, in oncology, automated systems can accelerate the testing of various drug responses on patient-specific cancer cells, allowing for more targeted treatment regimens. The ability of modular systems to adapt to the growing complexity of personalized medicine, combined with their ability to process vast amounts of data quickly, makes them invaluable tools in advancing personalized healthcare solutions and offers new growth opportunities for the market.

Restraints/Challenges

  • High Initial Investment Costs

A significant restraint for the modular laboratory automation market is the high initial investment required for purchasing and implementing automated systems. While these systems offer long-term efficiency gains, the upfront costs, including equipment, installation, and staff training, can be prohibitive for smaller laboratories or organizations with limited budgets. This is particularly challenging for academic institutions, research labs, or smaller pharmaceutical companies that may struggle to allocate resources for automation. For instance, a small biotech startup may be hesitant to invest in a fully automated modular system, fearing that the financial burden will outweigh the anticipated benefits. Even with the scalability of modular systems, the initial outlay can still be a barrier. This could delay the adoption of automation in certain markets, limiting the overall growth potential of the modular laboratory automation sector.

  • Integration with Existing Laboratory Infrastructure

A key challenge in the adoption of modular laboratory automation is ensuring seamless integration with existing laboratory infrastructure and workflows. Many laboratories rely on legacy equipment, instruments, or manual processes, which may not be compatible with modern automation systems. Integrating new automation solutions with older technologies can be complex, requiring significant adjustments to the lab's setup, protocols, and even employee skillsets. For instance, a laboratory using traditional manual pipetting or sample handling systems may struggle to integrate a new automated liquid handling module without substantial reorganization of workflows. This can lead to inefficiencies during the transition period and disrupt ongoing projects. The challenge of ensuring smooth integration requires careful planning, investment in system compatibility, and potentially modifying existing infrastructure, which can delay implementation and increase costs.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Modular Laboratory Automation Market Scope

The market is segmented on the basis of equipment and software and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Equipment and Software

  • Automated Liquid Handlers
  • Automated Plate Handlers
  • Robotic Arms
  • ASRS
  • Software and Analysers

Application

  • Drug Discovery
  • Genomics
  • Proteomics
  • Clinical Diagnostics

Modular Laboratory Automation Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, equipment and software, and application as referenced above.

The countries covered in the market report are U.S., Canada and Mexico, Germany, France, U.K., Italy, Russia, Spain, Denmark, Sweden, Norway, Rest of Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Nigeria, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.

North America is expected to dominate the modular laboratory automation market, driven by strong demand from industries such as pharmaceuticals, biotechnology, and healthcare. The region benefits from advanced research facilities, substantial investments in automation technologies, and a robust presence of leading market players. The U.S., in particular, is a key driver due to its focus on improving lab efficiency, reducing costs, and enhancing precision in research and diagnostics. In addition, innovations in AI and machine learning, along with favorable regulatory support, further strengthen North America's position as a leader in laboratory automation adoption.

Asia Pacific is expected to exhibit the highest growth rate in the modular laboratory automation market. The region is witnessing rapid advancements in life sciences, healthcare, and biotechnology, particularly in countries such as China, India, and Japan. Growing research and development activities, coupled with increasing investments in healthcare infrastructure, are driving demand for automation solutions. In addition, the rising focus on improving laboratory efficiency, reducing human error, and meeting high-throughput demands in emerging markets is fueling market growth. The region's expanding biotechnology sector and increasing adoption of automation technologies further contribute to its strong growth potential.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Modular Laboratory Automation Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Modular Laboratory Automation Market Leaders Operating in the Market Are:

  • Abbott (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • Aurora Biomed Inc. (Canada)
  • BD (U.S.)
  • BIOMÉRIEUX (France)
  • BioTek Instruments, Inc. (U.S.)
  • Brooks Automation US, LCC (U.S.)
  • Danaher Corporation (U.S.)
  • Eppendorf SE (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Honeywell International Inc. (U.S.)
  • Hudson Robotics (U.S.)
  • Hamilton Company (U.S.)
  • Interscience (France)
  • Oracle (U.S.)
  • PerkinElmer (U.S.)
  • QIAGEN (Germany)
  • Synchron (The Netherlands)
  • Siemens (Germany)
  • Thermo Fisher Scientific Inc. (U.S.)

Latest Developments in Modular Laboratory Automation Market

  • In October 2024, Oracle announced the general availability of Oracle Health Clinical Data Exchange, a new cloud-based solution designed to streamline medical claims processing through secure, automated data exchange between healthcare providers and payers. Built on Oracle Cloud Infrastructure (OCI), this solution replaces the time-consuming manual transmission of medical records with a secure, centralized network. It aims to reduce administrative time and costs, speed up the approval of essential patient clinical services, and accelerate claims and payment processing.
  • In June 2024, Roche announced the launch of its new analytical units, the cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions in countries that accept the CE mark. The cobas pro integrated solutions is a modular and scalable diagnostic platform tailored for high-volume laboratories. The cobas c 703 and cobas ISE neo units feature advanced technology designed to address key challenges faced by diagnostic laboratories globally, such as the shortage of qualified staff and space constraints.
  • ビオメリューは2024年6月、陽性血液培養から直接結果を報告するVITEK REVEAL ASTシステムが、米国食品医薬品局(FDA)の510(k)承認を取得したと発表しました。迅速かつ正確な抗菌薬感受性試験(AST)の結果とその解釈は、臨床医が迅速に治療を最適化し、患者ケアを向上させるために不可欠です。さらに、迅速なASTは、WHOが世界的な脅威として認識している抗菌薬耐性(AMR)に対抗できる可能性を秘めた抗菌薬適正使用(AMS)プログラムをサポートします。
  • 2024年1月、QIAGENはインドにおいて、QIAstat-Dx装置向けの2つの新しい症候群検査パネル(消化器パネル2と髄膜炎/脳炎パネル)の発売を発表しました。これらのパネルは、2020年に初めて緊急使用が承認された呼吸器系SARS-CoV-2パネルに加わります。両パネルは中央医薬品基準管理機構(CDSCO)の規制承認を取得しており、インドの医療従事者はより正確、迅速、かつ容易に患者を診断できるようになります。
  • 2023年5月、MolGenはオランダのオートメーション企業Synchron Instrumenten BVの買収を発表しました。この買収により、MolGenはポートフォリオを拡大し、DNA/RNA精製、ライブラリー調製、NGSセットアップのための高度な自動化ソリューションの開発能力を強化し、試薬事業を支えることができます。Synchronのカスタム液体ハンドリングプラットフォームとラピッドプロトタイピングに関する専門知識は、MolGenのオートメーション製品ラインナップをさらに拡充するために活用されます。
  • BD(ベクトン・ディッキンソン・アンド・カンパニー)は2023年1月、BD Kiestra微生物学ラボソリューション向けの新しいロボットトラックシステムを発表しました。このシステムは、検体処理を自動化し、手作業の削減と結果待ち時間の短縮を実現します。この新しいBD Kiestra第3世代トータルラボオートメーションシステムは、複数のBD Kiestraモジュールを接続することで、ラボがカスタマイズし、柔軟な自動化構成を構築できるようにします。また、様々なラボの独自のニーズや変化するニーズに対応できる拡張性も備えています。

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

市場は Segmentation, By Equipment and Software (Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, ASRS, Software, and Analysers), Application (Drug Discovery, Genomics, Proteomics, and Clinical Diagnostics) – Industry Trends and Forecast to 2032 に基づいて分類されます。
Global Modular Laboratory Automation Marketの規模は2024年にUSD 8.98 USD Billionと推定されました。
Global Modular Laboratory Automation Marketは2025年から2032年の予測期間にCAGR 6.76%で成長すると見込まれています。
市場で活動している主要プレーヤーはThermo Fisher ScientificInc., Danaher, BD, Abbott, Hamilton Company., bioMérieux SA, Siemens, F. Hoffmann-La Roche Ltd, QIAGEN, Honeywell International Inc. AGilent TechnologiesInc., BioTek InstrumentsInc., Hudson RoboticsInc., LabWare, Brooks AutomationInc., Cerner Corporation, Synchron Lab Automation, Aurora Biomed Inc., and PerkinElmer Inc.です。
この市場レポートはU.S., Canada and Mexico, Germany, France, U.K., Italy, Russia, Spain, Denmark, Sweden, Norway, Rest of Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Nigeria, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina and Rest of South Americaのデータを含みます。
Testimonial